Arrowgrass Capital Partners (US)’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-115,000	Closed	-$1.67M	–	213
2016 Q1	$1.67M	Buy	+115,000	New	+$1.67M	0.02%	145